Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Column Group LP Insider Profile
95 Followers
Column Group LP, Ten Percent Owner at Immune Design, holds 1.00K shares in NGM Biopharmaceuticals (Ticker: NGM), holds 2.82M shares in Nurix Therapeutics (Ticker: NRIX), holds 6.23M shares in Constellation Pharmaceuticals (Ticker: CNST).
Profitable Transactions
63 out of 82 Profitable Transactions
Average Return
+25.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Column Group LP's holdings
Insider Roles
Ten Percent Owner
Roles that Column Group LP holds in companies
Most Profitable Insider Trade
Stock:
Constellation Pharmaceuticals
(CNST)
(CNST)
Rating:Informative Buy
Date:Oct 07, 2019 - Oct 07, 2020
Return:+181.90%
The most profitable trade made by Column Group LP
Column Group LP's Trading History
Immune Design
Apr 02, 2019
―
Uninformative Sell
38.86M
$0.00
Constellation Pharmaceuticals
Feb 19, 2021
―
Informative Sell
369.50K
$211.78M
NGM Biopharmaceuticals
Apr 08, 2024
―
Uninformative Sell
―
$1.54K
Nurix Therapeutics
May 07, 2021
Ten Percent Owner
Uninformative Sell
―
$39.78M
List of latest transactions for each holding click on a transaction to see Column Group LP's performance on stock
You May Also Like
Column Group LP insider profile FAQ
What is the percentage of profitable transactions made by Column Group LP?
The percentage of profitable transactions made by Column Group LP is 77%.
What is the average return per transaction made by Column Group LP?
The average return per transaction made by Column Group LP is 25.40%.
What stocks does Column Group LP hold?
Column Group LP holds: IMDZ, CNST, NGM, NRIX stocks.
What was Column Group LP’s latest transaction?
Column Group LP latest transaction was an Uninformative Sell of ―.
What was Column Group LP's most profitable transaction?
Column Group LP’s most profitable transaction was an Informative Buy of CNST stock on October 7, 2019. The return on the trade was 181.90%.
What is Column Group LP's role in Immune Design?
Column Group LP's role in Immune Design is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.